LumiraDx said laboratories utilizing the SARS-CoV-2 RNA STAR Complete will be able to integrate Audere’s HealthPulse@home into their systems. Using HealthPulse@home authorized labeling instructions, labs can provide their own specimen-collection kit solution that fits into the lab’s preference of kit registration, accessioning, and flexibility of shipping carriers.
LumiraDx Fast Lab Solutions is a business unit that supports high-complexity laboratory testing by utilizing qSTAR nucleic acid amplification technology in an accessible high-throughput format to leverage current molecular laboratory operations.
Audere is a Seattle-based digital health nonprofit developing solutions to improve global health outcomes in the world’s most underserved communities. Audere combines smartphone technology, computer vision, machine learning, and cloud-based services to deliver tailored healthcare technology solutions worldwide. Development of the organization’s projects is funded by grants from the Bill & Melinda Gates Foundation and Justworks.
